Syneos Health® is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs and commercial capabilities to address modern market realities. Our focus on integration accelerates insights and performance — leading to better, smarter and more innovative solutions.
Watch the Conversations on Integration stories below to see how Syneos Health has demonstrated the advantages of implementing this collaborative approach for our customers’ businesses.
Learn More
Amplifying
Recruitment
Click on each of the solutions below to see how teams at Syneos Health used collaboration and integration to accelerate success across the product development lifecycle.
Syneos One, our fully integrated and insights-driven product development team, partnered with a small biotech company to deliver end-to-end product development. Watch the story of how Syneos One has worked to bring this high-value oncology asset to the market with reduced risk, increased speed and greater operational efficiency.
Learn More
Reinventing The
End-to-End Model
Contact Us
Dynamic Control Room
DIGITAL AMPLIFIER
SYNEOS ONE
Shortening the distance
from lab to life.
Forecasting
Solutions In Times
of Rapid Change
Learn More
See our Conversations on Integration below.
Reinventing the
End-to-end Model
SYNEOS ONE
AMPLIFYING RECRUITMENT
DIGITAL AMPLIFIER
Forecasting Solutions
In times of Rapid Change
DYNAMIC CONTROL ROOM
This story features the Syneos Health approach to integration as we identified and leveraged resources from across the organization to overcome a challenge in clinical trial recruitment. See how we combined agile technology, integrated insights and a commercial marketing tool — Digital Amplifier — to enhance clinical trial recruitment for an important, time-sensitive asset.
Syneos Health reacted to the global pandemic by incorporating new levels of data integration, expert interpretation and shared insights from every stage of the product lifecycle to develop a capability that helped with decision-making through the entire process. Watch the story of how Syneos Health built a dynamic network to accelerate actionable insights and operational efficiency in a time of rapid change.
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs and commercial capabilities to address modern market realities.
Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. We support a diverse, equitable and inclusive culture.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
© 2022 Syneos Health. All Rights Reserved | Terms of Use | Privacy Notice | Privacy Shield | Online Tracking Opt-Out
Syneos One
Digital Amplifier
Dynamic Control Room
Syneos One is a fully integrated, insights-driven, end-to-end product development offering that leverages a single point of contact for our customers through the entire lifecycle. A small biotech customer partnered with Syneos One to bring its life-changing asset to market. Our team navigated Phase II trials with them and we are now on the doorstep of bringing this important drug to market in early 2022.
Learn More
COVID-19 drug development demands a more fully integrated and holistic solution to provide emerging developers a powerful combination of asset strategy and execution.
An Integrative Approach to COVID-19 Drug Development
Watch Now
Learn how we successfully re-imagined a product launch at the start of
the pandemic.
Case Study: Pivoting Product Launch During COVID-19
Read Now
A fully integrated product development approach can provide companies a powerful combination of asset strategy and execution.
An End-to-End Product Development Methodology
Learn More
Understand how to engage with HCPs digitally to extend reach and impact.
Maximize Engagement Through Digital Amplification
Read Now
How can tech innovations help engage community HCPs in recruitment for clinical trials?
Harness Big Data to Accelerate Trial Recruitment
Watch Now
Reducing trial operational expenses often hinges on a key variable: speed
to enrollment.
A New Path to
Speed Enrollment
Read Now
Explore opportunities to optimize
the value and contributions of established brands.
Unlock Unprecedented Value in Established Brands
Watch Now
Uncover how to plan and implement a strategy to support established brands into their maturity.
The Advent of the
Established Brand
Read Now
Key learnings from a clinical development perspective suggest where the industry might be headed post-pandemic.
A Dynamic Control Room to Take on COVID-19
Learn more
A precise surround-sound digital
overlay to amplify sales teams
and existing call plans.
Driving Dynamic Success with Digital Amplifier
Read now
Build deeper relationships between HCPs and reps by creating more meaningful healthcare interactions.
A Modern Approach to Driving Sales Force Success
PRODUCT DEVELOPMENT LIFECYCLE
Commercial
Delivery
Clinical
Development
Maturity
Growth
Product Launch
Phase IIb/III
Phase IIa
Phase I
Sales Reps - Tele Detailing - Training - Sales OPS
Brand & Company Public Relations - Advertising - Data Science - Digital - Social Media
Naming & Branding Assets & Studies
Commercial Strategy - Portfolio Strategy - Corporate Developement
Access Account Managers, Field Reimbursement Specialists, Training & Deployment
Risk Mitigation - Reputation Management - Public Affairs - Policy & Advocacy - Stakeholder Engagement
Market Access - Pricing & Contracting Strategy - Health Economic Models - Payer Communications
Nurse Educators
Medical Field Team Recruitment, Training & Deployment
Risk Evalutation & Mitigation & Education
Medical Strategy - Evidence Generation - Medical Comms - Congresses - Disease Awareness - Stakeholder Engagement - Training & Education
Regulatory Strategy, Submissions, & Operations
RWE Label Extension & Value-Based Contracting
RWD Clinical Trial Design - RWD Regulatory Submissions
Phase IIa - III Clinical Development
Bioanalytics & Biomarker Solutions
Phase I Proof of Concept Development
Phase I Clinical Development
Visit Syneoshealth.com for more info
Medical
Affairs
Commercial
Delivery
Medical
Affairs
Clinical
Development
Maturity
Growth
Product Launch
Phase IIb/III
Phase IIa
Phase I
Sales Reps - Tele Detailing - Training - Sales OPS
Brand & Company Public Relations - Advertising - Data Science - Digital - Social Media
Naming & Branding Assets & Studies
Commercial Strategy - Portfolio Strategy - Corporate Developement
Access Account Managers, Field Reimbursement Specialists, Training & Deployment
Risk Mitigation - Reputation Management - Public Affairs - Policy & Advocacy - Stakeholder Engagement
Market Access - Pricing & Contracting Strategy - Health Economic Models - Payer Communications
Nurse Educators
Medical Field Team Recruitment, Training & Deployment
Risk Evalutation & Mitigation & Education
Medical Strategy - Evidence Generation - Medical Comms - Congresses - Disease Awareness - Stakeholder Engagement - Training & Education
Regulatory Strategy, Submissions, & Operations
RWE Label Extension & Value-Based Contracting
RWD Clinical Trial Design - RWD Regulatory Submissions
Phase IIa - III Clinical Development
Bioanalytics & Biomarker Solutions
Phase I Proof of Concept Development
Phase I Clinical Development
Commercial
Delivery
Medical
Affairs
Clinical
Development
Maturity
Growth
Product Launch
Phase IIb/III
Phase IIa
Phase I
Sales Reps - Tele Detailing - Training - Sales OPS
Brand & Company Public Relations - Advertising - Data Science - Digital - Social Media
Naming & Branding Assets & Studies
Commercial Strategy - Portfolio Strategy - Corporate Developement
Access Account Managers, Field Reimbursement Specialists, Training & Deployment
Risk Mitigation - Reputation Management - Public Affairs - Policy & Advocacy - Stakeholder Engagement
Market Access - Pricing & Contracting Strategy - Health Economic Models - Payer Communications
Nurse Educators
Medical Field Team Recruitment, Training & Deployment
Risk Evalutation & Mitigation & Education
Medical Strategy - Evidence Generation - Medical Comms - Congresses - Disease Awareness - Stakeholder Engagement - Training & Education
Regulatory Strategy, Submissions, & Operations
RWE Label Extension & Value-Based Contracting
RWD Clinical Trial Design - RWD Regulatory Submissions
Phase IIa - III Clinical Development
Bioanalytics & Biomarker Solutions
Phase I Proof of Concept Development
Phase I Clinical Development
Syneos One
Digital Amplifier
Dynamic Control Room
For an urgent therapeutic product, our team saw an opportunity to use a commercial tool to overcome lagging clinical trial enrollment in Phase II trials. Using Digital Amplifier – a precision digital marketing tool – the team was able to recruit patients through their healthcare professionals, generating an almost immediate increase in trial enrollment. This novel approach was an important factor in accelerating this treatment to market and was organically born from the Syneos Health product development mindset for problem-solving.
Amid the complex environment of a fast-moving global health crisis, there was an immediate need to develop and launch treatments in a very short period. Navigating the COVID-19 landscape required new levels of data integration, expert interpretation and shared insights from across the entire organization. Our team created a Dynamic Control Room delivering a real-time network of insights to understand where the next outbreaks would occur. This Digital Control Room enabled our customers to act faster and bring their assets to market more efficiently.
Read Now
A fully integrated product development approach can provide companies a powerful combination of asset strategy and execution.
An End-to-End Product Development Methodology
Read Now
Watch now.
Case Study: Pivoting Product Launch During COVID-19
Watch Now
Learn how we successfully re-imagined a product launch at the start of the pandemic.
Case Study: Pivoting Product Launch During COVID-19
Read Now
A fully integrated product development approach can provide companies a powerful combination of asset strategy
and execution.
An End-to-End Product Development Methodology
Read Now
How can tech innovations help engage community HCPs in recruitment for clinical trials?
Harness Big Data to Accelerate Trial Recruitment
Learn More
Understand how to engage with HCPs digitally to extend reach and impact.
Maximize Engagement Through Digital Amplification
Read now
Build deeper relationships between HCPs and reps by creating more meaningful healthcare interactions.
A Modern Approach to Driving Sales Force Success
Learn More
Understand how to engage with HCPs digitally to extend reach and impact.
Maximize Engagement Through Digital Amplification
Read Now
How can tech innovations help engage community HCPs in recruitment for clinical trials?
Harness Big Data to Accelerate Trial Recruitment
Watch Now
Reducing trial operational expenses often hinges on a key variable: speed to enrollment.
A New Path to
Speed Enrollment
Click on each of the solutions below to see how teams at Syneos Health used collaboration and integration to accelerate success across the product development lifecycle.
Syneos One is a fully-integrated, insights-driven, end-to-end product development offering that leverages a single point of contact for our customers through the entire lifecycle. A small biotech customer partnered with Syneos One to bring its life-changing asset to market. Our team navigated Phase II trials with them and are now on the doorstep of bringing this important drug to market in early 2022.
Syneos One is a fully-integrated, insights-driven, end-to-end product development offering that leverages a single point of contact for our customers through the entire lifecycle. A small biotech customer partnered with Syneos One to bring its life-changing asset to market. Our team navigated Phase II trials with them and are now on the doorstep of bringing this important drug to market in early 2022.
®
®
®